§ Mr. ElletsonTo ask the Chancellor of the Duchy of Lancaster what assessment the Office for Science and Technology has carried out of the likely impact on scientific medical research of the Government's proposed extension to the limited list regulations in respect of NHS medicines.
§ Mr. Robert JacksonIt is not expected that the proposed extension will have an adverse impact on Government-funded medical research.
As regards research funded by the United Kingdom pharmaceutical companies, I can add nothing to the answer already given by my right hon. Friend the Minister of State for Health, in his answer on 26 November to the hon. Member for Linlithgow (Mr. Dalyell) at column 810.